SecBot SecBot
Insider Cluster (2 insiders) ·Filed Aug 12, 2026

AMPH

Amphastar Pharmaceuticals, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed2mo ago
Insider cluster: 2 insiders, $346K total
Actionable Insight • Neutral

This cluster is routine and non-informative. The CFO's sale is tied to option exercise, not a bearish view. No follow-up action warranted — monitor next 10-Q for fundamental trends rather than insider activity.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d
AMPH ▲ +17.84% at T+20d
NEUTRAL call +17.84% · α vs SPY +19.59% · entry $20.18 → $23.78
Next anchor: T+60d in 9d
Latest observation: T+50 +17.21% FF3 residual α
Entry = T+0 close
Aug 12, 2026
via day close
T+1d
+3.62%
call +3.62% · α +3.82%
$20.91
settled 3mo ago
T+5d
+7.43%
call +7.43% · α +9.40%
$21.68
settled 2mo ago
T+20d
+17.84%
call +17.84% · α +19.59%
$23.78
settled 7w ago
T+60d
Pending
in 9d

Price Chart

Loading chart...

Executive Summary

Two Amphastar insiders — Director Richard Prins and CFO William Peters — sold a combined $346K in open-market shares over a 7-day window. The CFO's sale coincided with the exercise of stock options, a routine pattern that reduces the informational signal. At $869M market cap, the $346K represents ~0.04% of equity — well below the 0.1% threshold for materiality. The cluster is a routine liquidity event, not a bearish signal.

Key Financial Metrics

Direction
selling
Total Value
$346.0K
Insiders
2

Key Facts

  • Two insiders sold a combined $346K in open-market shares over 7 days (Aug 4–11, 2026)
  • CFO William Peters sold $184K while simultaneously exercising options for $100K — a standard cashless exercise pattern
  • Director Richard Prins sold $162K on Aug 11 at $20.30/share
  • Total sales represent ~0.04% of Amphastar's $869M market cap — trivial
  • No insider purchases occurred in the cluster

Financial Impact

$346K total insider sales, ~0.04% of market cap

insider ownership

Risk Factors

  • Insider sales could accelerate if stock price weakens further (currently ~$20, near 52-week lows)

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
0% bullish (12 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-AMPH-1786572926541
8 reports for AMPH
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for AMPH — sortable, filterable
TypeNow
Sep 23, 2026
4w ago
Insider Cluster
NEUTRAL ★ 3/10
$26.27awaiting T+60—$25.57 (−2.66%)
Sep 21, 2026
5w ago
144
NEUTRAL ★ 2/10
$24.32awaiting T+60—$25.57 (+5.14%)
Aug 21, 2026
9w ago
Institutional Cluster
MIXED ★ 4/10
$21.60awaiting T+60—$25.57 (+18.38%)
Aug 12, 2026
10w ago
Insider Cluster
NEUTRAL ★ 2/10
$20.18awaiting T+60—$25.57 (+26.71%)
Aug 11, 2026
11w ago
144
NEUTRAL ★ 2/10
$20.31awaiting T+60—$25.57 (+25.90%)
Jul 13, 2026
15w ago
8-K
NEUTRAL ★ 2/10
$19.29 $25.91▲ +34.32%▲ +30.32%$25.57 (+32.56%)
Jul 7, 2026
15w ago
8-K
BEARISH ★ 6/10
$18.88 $25.35▼ −34.27%▼ −31.78%$25.57 (−35.43%)
Apr 13, 2026
28w ago
DEFA14A
NEUTRAL ★ 3/10
$21.38 $19.02▼ −11.04%▼ −19.56%$25.57 (+19.60%)
Showing 8 of 8

US Market Status

Market Closed — Opens Wed (15h 46m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 12, 2026